Dr. Ali Shahbazi, Patrícia Figueiredo, João Martins and Tomás Ramos, presented their works at the CRS 46th Annual Meeting in Valencia The 2019 Controlled Release Society Annual Meeting & Exposition ...

Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Kala researchers ...

Annual Meeting and Exposition, from Jul 17–20 in Seattle, WA. Celanese VitalDose EVA, a controlled release material, is meeting the increasing needs of the industry as pharmaceutical companies ...

Novozymes Biopharma, has announced two new scientific posters to be presented at the 2011 Controlled Release Society (CRS) meeting and exposition, July 30-August 3, Maryland, USA. The posters ...

announced today the official commercial launch of NxGen Blaze and NxGen blaze+ at the 2019 CRS Annual Meeting & Exposition July 21st-24th, in Valencia, Spain. The proprietary NxGen microfluidic ...